We are live on ! Find out more
OGEN icon

Oragenics

18 hedge funds and large institutions have $169K invested in Oragenics in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

13% more funds holding

Funds holding: 1618 (+2)

5% more capital invested

Capital invested by funds: $161K → $169K (+$8.73K)

2.22% more ownership

Funds ownership: 2.97%5.18% (+2.2%)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q4 2025 in Review

18 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2025, worth a combined $169K — up 5.4% from $161K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OGEN positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was DRW Securities, adding an estimated $55.2K. The largest seller was Allworth Financial, exiting entirely with an estimated $438 sold.

  • 18 institutional investors held Oragenics (OGEN) as of Q4 2025, up from 16 in Q3 2025.
  • Funds reported $169K of Oragenics stock for Q4 2025, up 5.4% quarter-over-quarter.
  • 4 funds opened new Oragenics positions in Q4 2025 and 2 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q4 2025 was DRW Securities, an estimated $55.2K added.
  • The largest Oragenics seller in Q4 2025 was Allworth Financial, an estimated $438 sold.

Based on aggregated 13F filings for Q4 2025.